In a final written decision of an inter partes review proceeding, the Patent Trial and Appeal Board found all 12 claims of a challenged patent unpatentable as either anticipated or obvious. Each ground of unpatentability relied, in whole or in part, on Patent Owner’s own prior art, including clinical trials published at ClinicalTrials.gov.